groups
Population | Subjects, N | PST sessions, N | Therapists | Treatment fidelity | Primary outcome | Summary of results | Rovner et al., 2013 [ ] | PST vs. ST | Patients of retina clinics | 241 | 6 in 12 wk | Bachelor's- or master's-level graduates of social sciences | 30% of audiotaped sessions; supervision | Targeted vision function | PST was not superior to ST in improving vision function in patients with age-related macular degeneration; PST improved vision-related quality of life. |
Choi et al., 2013 [ ] | Tele-PST vs. in-person PST vs. TS | Homebound older adults from aging-network agencies | 121 | 6 weekly | Licensed master's-level social workers | 2 sessions of 20% of subjects | Acceptance of PST; depression | Both PST groups showed acceptance of PST. Tele-PST and in-person PST depression scores were significantly lower at 12 wk than scores of participants in the TS condition; gains were maintained at 24 wk. |
Chan et al., 2012 [ ] | EN+PST vs. EN vs. PST vs. control | Community-dwelling older adults | 117 | 6 in 3 mo | Trained case managers | NR | Frailty (CHS-PCF) | No significant differences in the measures of primary outcome between participants who received PST and those who did not |
Demiris et al., 2012 [ ] | Face-to-Face PST vs. PST via videophone | Family hospice caregivers from urban hospice agencies | 126 | 3 in 20 d | Registered nurses and master's-level social workers | 10% of sessions were reviewed | Caregiver quality of life/anxiety | No significant differences between the two groups in improvement of quality of life and reduction of anxiety |
Alexopoulos et al., 2011 [ ]; Areán et al, 2010 [ ] | PST vs. ST | Clinician referrals and responders to advertisement | 221 | 12 weekly | Doctoral-level clinical psychologists and licensed social workers | 20% of sessions reviewed; supervision | Depression/disability | PST participants had significantly greater reduction in depression and disability than ST participants at 12 wk. |
Kiosses et al., 2010 [ ] | PATH vs. ST-CI | Responders to advertisement and referrals from collaborative agencies | 30 | 12 weekly | Doctoral-level clinical psychologists and licensed social workers | Supervision | Depression/disability | Participants in PATH (PST + environmental adaptations + caregiver involvement) had significantly greater reduction in depression and disability than ST participants over 12 wk |
Gellis et al., 2010 [ ] | PST-HC vs. UC+E | Home-care agency patients | 38 | 6 in 6 wk | Master's-level social workers | Supervision | Depression/anxiety | Participants in PST-HC had significantly greater reduction in depression but not anxiety than UC+E participants. |
Lam et al., 2009 [ ] | PST-PC vs. group-video PBO | Outpatient clinics | 291 | 3 in 6 wk | Primary care doctors | Random sample of 1st session of 3 subjects per doctor | Quality of life | Mixed-effects model analysis did not show significant differences in outcome measure between the two groups. Participants receiving PST-PC had significant improvement in role-emotional and mental component summary (SF-36 Health-Related Quality of Life) at the end of treatment. The PBO group showed no such improvement. |
Robinson et al., 2008 [ ]; Mikami et al., 2013 [ ] | Escitalopram vs. PBO vs. PST | Stroke patients | 176 | 6 in 1st 12 wk; 6 booster sessions in following 9 mo | NR | Reviews of audiotaped or videotaped sessions; supervision | Onset of MDD or minor depression | Depression [ ]: Among stroke patients, PST participants were less likely to develop a major or minor depressive episode than the PBO group. This difference became nonsignificant in a more conservative analysis, which assumed that baseline patients who did not continue the study would have developed depression. Apathy [ ]: Escitalopram or PST was significantly more effective in preventing new onset of apathy following stroke compared with PBO. |
Gellis et al., 2007 [ ] | PST-HC vs. UC | Home-care agency patients | 40 | 6 in 8 wk | Master's-level social workers | Supervision | Depression/quality of life | Participants in PST-HC had greater reduction in depression and greater improvement in quality of life over the course of 6 mo. |
Rovner et al., 2007 [ ]; Rovner and Casten, 2008 [ ] (prevention study) | PST vs. UC | Patients of retinovitreous clinics | 206 | 6 in 8 wk | Nurses and master's-level counselor | 1/3 of sessions reviewed | Onset of MDD | PST-treated participants had significantly lower 2-mo incidence rates than UC participants. Participants in PST were less likely than UC participants to suffer persistent depression at 6 mo, even though most earlier benefits were diminished. |
Downe-Wamboldt et al., 2007 [ ] | Telephone PST+UC vs. UC | Patients of academic center cancer clinic | 149 | Sessions varied in 3 mo based on negotiation with patient | Nurse counselor | Examinationof nurses' written records | Coping/depression/p sychosocial adjustment | Participants in PST demonstrated greater improvement in certain coping areas at 8 mo (5 mo after treatment) compared with UC participants. There were no significant differences between the two groups in depression and psychosocial adjustment. |
Alexopoulos et al., 2003 [ ] | PST vs. ST | Clinician referrals and responders to advertisement | 25 | 12 weekly | Doctoral-level clinical psychologists and licensed social workers | Review of 1st, 6th, and 12th sessions of half the subjects | Depression/disability | PST group had greater reduction in depression scores at 12 wk than ST group. PST led to a more rapid improvement in disability at 12 wk than ST. |
Williams et al., 2000 [ ] | Paroxetine vs. PBO vs. PST-PC | Referrals from community, veterans affairs, and primary care clinics | 415 | 6 over 11 wk | Doctoral-level psychologists, social workers, and counselors with master's degree | Therapists certified as competent in PST | Depression | All groups had significant reduction in depression. The paroxetine group had significantly greater reduction in depression than the PBO group, and PST-PC participants had a reduction comparable with that of participants in the other two groups. |
Areán et al., 1993 [ ] | Group PST vs. group RT vs. WLC | Community-dwelling older adults | 75 | 12 weekly group sessions | Advanced graduate students in clinical psychology | Supervision | Depression | Participants in PST had significantly less depression post treatment than participants in RT and those in WLC. |
CHS-PCF, Cardiovascular Health Study–Phenotypic Classification of Frailty; EN, exercise and nutrition program; MDD, major depressive disorder; NR, ; PATH, problem adaptation therapy; PBO, placebo; PST, problem-solving therapy; PST-HC, problem-solving therapy–home care; PST-PC, problem-solving therapy–primary care; RT, reminiscence therapy; ST, supportive therapy; ST-CI, supportive therapy for cognitively impaired older adults; TS, telephone support calls; UC, usual care; UC+E, usual care plus education; WLC, waiting-list condition.
Finally, ongoing clinical trials, not included in the current review, focus on using PST or adaptations of PST to a) reduce depression in low-income, homebound [ 6 ], medically ill older adults [ 7 , 8 ] and opiate abusers [ 9 ] or b) prevent the onset of depressive episodes in high-risk elders [ 10 ].
We searched PubMed (1966–2013), PsycNET (1840–2013), and Cochrane databases, emphasizing studies from the past 5 years. The searches were conducted using the following keywords: “problem solving therapy,” “PST,” “old*,” and “eld*” (the asterisk denotes any combination of the word). In addition, we selected appropriate studies from previously published meta-analyses and reviews. Inclusion criteria of studies were a) an RCT using problem-solving therapy [ 4 , 5 ], b) published in English, and c) with the average participant 60 years old or older. This review does not include interventions that included PST as only one aspect or step of the treatment (e.g., IMPACT, PEARL, or other stepped-cared programs), because PST was given in combination with other depression interventions and the relative effect of PST could not be determined. We identified 734 abstracts and potential articles through our searches, 15 of which were original RCTs that met our criteria; of those, 12 were published in the past 5 years (see Table 1 for the characteristics of the 15 RCTs). Two of 15 were prevention studies in patients with macular degeneration and stroke. The following treatment options are based mainly on results from the analyses of primary outcomes.
Diagnosed major depression
The results are based on four studies of PST [ 11• class I study, 12 – 14 ]. Two multisite studies [ 11• , 12 , 15 ] used a PST adaptation for depressed patients with executive dysfunction (PST-ED) and another study used a PST adaptation (PATH) for depressed patients with advanced cognitive impairment including dementia [ 14 ]. All studies used depression treatment as a control condition (reminiscence therapy [RT] [ 13 ]; supportive therapy [ST] [ 11• class I study, 12 , 14 ].
Despite the strong control condition, PST showed significantly greater reduction in depression post treatment. In one study [ 13 ], the benefits of group PST vs. group RT were maintained at 24 weeks.
Standard procedure
- PST-ED [ 11• class I study, 12 ]: 12 sessions in 12 weeks delivered by doctoral-level clinical psychologists and licensed social workers.
- Home-delivered PATH (problem adaptation therapy) [ 14 ]: 12 sessions in 12 weeks delivered by doctoral-level clinical psychologists and licensed social workers.
- PST [ 13 ]: 12 weekly group sessions delivered by advanced graduate students in clinical psychology.
Special points
- Depressed older adults with executive dysfunction: Participants in PST-ED had a significantly greater reduction in depression than participants in ST over 12 weeks in two multisite studies. Cohen's d ranged from 1.08 [ 12 ] to 0.48 [ 11• class I study]. However, Cohen's d for the 2003 study by Alexopoulos et al. [ 12 ] must be interpreted with caution because of the small sample size.
- Depressed older adults with advanced cognitive impairment: Participants in home-delivered PATH had a significantly greater reduction in depression than participants in home-delivered ST. Cohen's d was 0.77, but it also must be interpreted with caution considering the small sample size (N = 30) [ 14 ].
- Participants in group PST show a greater reduction in depression at 3 months (post treatment) than participants in group RT and those in the wait-list control condition. Estimated Cohen's d between PST vs. RT was 1.08.
Minor depression, dysthymia, or depression symptoms
The results are based on three studies of PST-PC [ 16• class I study] in minor depression or dysthymia and PST-HC [ 17 , 18 ] in depression in home-care patients. Compared with usual care, PST had a greater reduction in depression in home-care patients; however, compared with paroxetine or placebo, PST had a reduction in depression similar to that of paroxetine and placebo in patients with dysthymia and minor depression.
- PST-PC: Six sessions in 11 weeks delivered by doctoral-level psychologists, social workers, and counselors with master's degrees.
- PST-HC: Six sessions in 6 [ 18 ] or 8 weeks [ 17 ] delivered by master's-level social workers.
- PST-PC participants had a reduction in depression comparable to that of participants in the placebo or paroxetine group among patients with dysthymia or minor depression.
- Among home-care patients with subthreshold depression and cardiovascular disease, participants in PST-HC had a significantly greater reduction in depression than usual-care participants.
- Among home-care patients with significant depressive symptoms, participants in PST-HC had a greater reduction in depression and greater improvement in quality of life over the course of 6 months than usual-care participants.
Prevention of depression and apathy
The results are based on two studies of prevention in patients with macular degeneration ([ 19• ] and [ 20 ] used the same sample) and stroke patients ([ 21• ] and [ 22 ] used the same sample). In one study, the outcome was prevention of a major depressive episode [ 19• class I study, 20 ], whereas in the other, the outcome was prevention of a major or minor episode of depression [ 21• class I study] or prevention of onset of apathy [ 22 ].
Stroke patients participating in PST were less likely to develop a major or minor depressive episode than those in the placebo group. This difference became nonsignificant in a more conservative analysis, which assumed that baseline patients who did not continue the study would have developed depression. Among patients with macular degeneration, PST participants had significantly lower 2-month incidence rates of major depression than usual-care participants and were less likely to suffer persistent depression at 6 months. In a recent analysis of the study sample of Robinson et al. [ 21• ] of the subjects who did not exhibit apathy at baseline, escitalopram or PST was significantly more effective in preventing new onset of apathy following stroke compared with placebo [ 22 ].
- Patients with macular degeneration [ 19• class I study, 20 ]: six sessions in 8 weeks delivered by nurses and master's-level counselors.
- Stroke patients [ 21• class I study, 22 ]: six sessions in the first 12 weeks and six reinforcement sessions in the following 9 months.
- Stroke study [ 21• class I study]: placebo participants were 2.2 times more likely than PST participants and 4.5 times more likely than escitalopram participants to develop depression.
- Stroke study [ 22 ] (outcome: onset of apathy): placebo participants were 3.47 times more likely than escitalopram patients and 1.84 times more likely than PST patients to develop apathy.
Functioning, frailty, and quality of life
The results are based on three studies of PST [ 12 , 15 , 14 ]. Two multisite studies [ 12 , 15 ] used PST-ED; the other study used PATH for depressed patients with advanced cognitive impairment including dementia [ 14 ]. All studies used depression treatment as a control condition (ST) [ 12 , 14 , 15 ].
PST participants had significantly greater reduction in disability at 12 weeks than ST participants in all three studies. In one study [ 15 ], the benefits of PST vs. ST were sustained between 12 and 36 weeks.
- PST-ED [ 12 , 15 ]: 12 sessions in 12 weeks delivered by doctoral-level clinical psychologists and licensed social workers.
- Home-delivered PATH (problem adaptation therapy) [ 14 ]: 12 sessions in 12 weeks delivered by a doctoral-level clinical psychologist and licensed social worker.
Exploratory analyses revealed that disability mediated the effects of depression at the end of treatment (12 weeks).
Targeted vision function
The results are based on only one study of patients with age-related macular degeneration [ 23 ]. PST participants did not have greater improvement in vision function than ST participants in the primary outcome measure at 3 months (end of treatment) or 6 months but had greater improvement in the secondary outcome of vision-related quality of life [ 23 ].
- Six sessions in 12 weeks delivered by therapists with a bachelor's or master's degree.
- PST targeting functional problems of vision loss and reducing the difficulty of vision-dependent tasks did not show significant improvement over ST at 3 and 6 months after baseline [ 23 ].
- PST showed greater improvement in the secondary outcome of vision-related quality of life compared with ST.
The results are based on only one study of frail community older adults [ 24 ]. Participants receiving PST did not have significant improvement in any of the frailty measures: weight loss, exhaustion, low activity level, slowness, and weakness.
- Six sessions in 3 months delivered by trained case managers.
Quality of life
The results are based on one study [ 25 ] focusing on a group of outpatients who screened positive for psychological problems by the Chinese version of the Hospital Anxiety and Depression Scale. PST-PC participants had improvement in health-related quality of life comparable with that of placebo participants who watched health education videos.
- PST-PC: three sessions in 6 weeks delivered by primary care doctors.
Although participants in PST-PC had significant improvement in the role-emotional and mental components of the SF-36 Health-Related Quality of Life assessment at week 6, whereas the placebo group did not, a mixed-effects analysis accounting for potential covariates and baseline measures did not show any difference between the two groups in any outcome.
Alternative deliveries
- Older adults who are homebound or live in rural areas may need alternative ways to deliver PST, such as phone, videophone, or Internet.
- Special considerations are required for patients with hearing and vision problems as well as patients with cognitive impairment.
The results are based on three studies of PST delivered through telephone [ 26 ], videophone [ 27 ], or Skype [ 28 ]. The subjects for each study were cancer patients [ 26 ], hospice caregivers [ 27 ], and home-care patients with depression [ 28 ].
- Telephone: varied number of sessions (based on negotiation with the patient) in 3 months delivered by nurse counselors.
- Videophone: three sessions in 20 days.
- Skype: six weekly sessions.
Special Points
- Delivering PST through phone, videophone, and Internet is feasible and acceptable to vulnerable older adults.
- PST counseling delivered over the phone to cancer patients showed greater improvement in certain coping areas than usual care, but there were no significant differences in reduction of depression or improvement in psychosocial adjustment.
- Videophone-delivered PST showed improvement in caregiver quality of life and reduction in anxiety compared with in-person PST.
- PST delivered through Skype demonstrated results comparable with those of in-person PST in homebound older adults, and both PST conditions showed a greater reduction in depression compared with a condition of support calls [ 28 ]. Among patients in the sample, 67% had major depressive disorder, 29% had minor depression, and 4% had dysthymia.
Considerations
Length of treatment.
- Ten of 15 studies had between 6 and 12 PST sessions in 12 weeks.
- The two prevention studies had six sessions in 8 or 12 weeks, and one of them [ 21• , 22 ] had six additional sessions in the following 9 months.
Therapists and treatment fidelity
- Therapists included those with a bachelor's or master's degree in social science, master's-level social workers, nurse counselors, advanced graduate students in clinical psychology, and doctoral-level clinical psychologists.
- Reviews of recorded sessions and notes were performed in 9 of 15 studies.
Race, education, and socioeconomic status
- The majority of participants in most studies were older Caucasian adults with at least 12 years of education. Two studies were conducted in Hong Kong [ 25 ] and in Taiwan [ 24 ]. Future research will focus on racially diverse participants, as well as those with limited education and low socioeconomic status.
Cognitive impairment and dementia
- Older adults with cognitive impairment also may need compensatory strategies, including written session notes, memory devices, environmental adaptations, and caregiver participation, to help them with their cognitive deficits.
Acknowledgments
This paper was supported in part by grants from the National Institute of Mental Health (R01 MH075897, R01 MH076829, and P30 MH085943 [to George S. Alexopoulos] and R01 MH091045 [to Dimitris N. Kiosses]) and an Alzheimer's Association Investigator Initiated Research Grant (to Dimitris N. Kiosses).
George S. Alexopoulos has served as a consultant for Pfizer and Otsuka, has received grants from Forest Laboratories, and has received payment for lectures, including service on speakers bureaus, from AstraZeneca, Avanir Pharmaceuticals, Novartis, and Sunovion.
Compliance with Ethics Guidelines: Conflict of Interest : Dimitris N. Kiosses declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent : This article does not contain any studies with human or animal subjects performed by any of the authors.
Contributor Information
Dimitris N. Kiosses, Weill-Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College.
George S. Alexopoulos, Weill-Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College.
Papers of particular interest have been highlighted as:
• Of importance
IMAGES
VIDEO
COMMENTS
The Effectiveness of Problem-Solving Therapy for Primary ...
Background: There is increasing demand for managing depressive and/or anxiety disorders among primary care patients. Problem-solving therapy (PST) is a brief evidence- and strength-based psychotherapy that has received increasing support for its effectiveness in managing depression and anxiety among primary care patients.
Updated: July 1, 2021. Problem-Solving Treatment (PST) is a brief form of evidence-based treatment that was originally developed in Great Britain for use by medical professionals in primary care. It is also known as Problem-Solving Treatment - Primary Care (PST-PC). PST has been studied extensively in a wide range of settings and with a ...
Problem-Solving Therapy for Primary Care was developed as an efficient modality to treat patients in busy primary care settings over the course of 4-8 sessions. It has been found that as few as three sessions of PST-PC could be beneficial (Mynors-Wallis et al., 2000; ...
The Rationale for Problem-Solving Treatment in Primary Care Research has shown that minor life events or problems are strongly associated with psychological symptoms, in particular depression, possibly even more so than major life events ... Thus, earlier models of problem solving therapy were meant to be delivered in one-hour individual ...
for primary care depression and anxiety studies published between January 1900 and September 2016. We also E-mailed major authors of PST studies for feedback and input. Search terms of title and/or abstract searches included: ["PST" or "Problem-Solving Therapy" or "Problem Solving Therapy" or "Problem Solving"] AND ["Depres-
and/or anxiety in primary care, and found support for the effectiveness of PST for depression and/or anxiety. Results also indicated that physician-involved PST offers meaningful improvements for primary care patients' depression and/or anxiety. 4. Gellis Z, et al. (2007). Problem-solving therapy for late-life depression in home care: a randomized
Problem-Solving Therapy: Definition, Techniques, and ...
The Use of Problem-Solving Therapy for Primary Care to Enhance Complex Decision-Making in Healthy Community-Dwelling Older Adults Front Psychol. 2018 Jun 13; 9:870. doi ... These findings demonstrated that a four-session problem-solving therapy can reinforce aspects of executive functioning (that may have declined as a part of healthy aging ...
Problem-solving therapy for primary care (PST-PC; Mynors-Wallis, Gath, Lloyd-Thomas, & Tomlinson, 1995) is a psychotherapeutic intervention created specifically to address the time and resource issues present in primary care medicine; it is a brief intervention, lasting between four and eight sessions, and is adapted so that non-mental-health ...
Evidence-Based Behavioral Interventions in Primary Care
Problem solving therapy has been described as pragmatic, effective and easy to learn. It is an approach that makes sense to patients and professionals, does not require years of training and is effective in primary care settings. 1 It has been described as well suited to general practice and may be undertaken during 15-30 minute consultations. 2 ...
Purpose: We compared a primary-care-based psychotherapy, that is, problem-solving therapy for primary care (PST-PC), to community-based psychotherapy in treating late-life major depression and dysthymia. Design and methods: The data here are from the IMPACT study, which compared collaborative care within a primary care clinic to care as usual in the treatment of 1,801 primary care patients, 60 ...
Problem-solving therapy (PST) is a cognitive-behavioral intervention that focuses on training patients to use effective problem-solving skills. Effective problem solving is thought to mitigate the negative impact of stress on well-being . ... all of which are frequent problems among primary care patients. Advances in collaborative care and ...
Background: There is increasing demand for managing depressive and/or anxiety disorders among primary care patients. Problem-solving therapy (PST) is a brief evidence- and strength-based ...
The problem solving treatment tested in the current study for minor depression is a brief variant of social problem solving therapy (D'Zurilla & Nezu, 1999). It is a psychosocial skills training intervention originally designed and tested in the United Kingdom as a treatment for emotional distress in primary care ( Catalan, Gath, Bond, Day ...
This article describes problems identified by older primary care patients enrolled in Problem Solving Therapy (PST), and explores factors associated with successful problem resolution. PST patients received 1 to 8, 45-min sessions with a social worker. Patients iden-tified problems in their lives and directed the focus of subsequent
structure of agenda setting, reviewing progress, engaging in the PST model problem-solving activities (described above), reviewing action plans, and wrap up. PST has been adapted for use with a variety of patient populations, including those in primary care and those who are homebound, medically ill, and elderly.
The skills of assessment and diagnosis of psychiatric disorders in primary care have been identified and effectively taught by Goldberg, Gask, and their colleagues in Manchester (), and will not be detailed here.This chapter will focus on one particular psychological treatment in primary care, namely, problem-solving (D'Zurilla and Goldfried, 1971).
Problem-solving therapy for primary care (PST-PC; Mynors-Wallis, Gath, Lloyd-Thomas, & Tomlinson, 1995) is a psychotherapeutic intervention created specifically to address the time and resource issues present in primary care medicine; it is a brief intervention, lasting between four and eight sessions, and is adapted so that non-mental-health ...
There is limited evidence that interventions for depression and other common mental disorders (CMD) can be integrated sustainably into primary health care in Africa. We aimed to pilot a low-cost multi-component 'Friendship Bench Intervention' for CMD, locally adapted from problem-solving therapy and delivered by trained and supervised female lay workers to learn if was feasible and possibly ...
PST can be effectively delivered in primary care settings by psychiatrists, general practitioners, or nurses. PST may be more expensive than primary care practitioners' usual treatment in terms of direct costs. However, PST might result in greater savings if indirect costs are also considered. Conclusions: PST is a feasible, brief, effective ...
Introduction. Late-life depression worsens the outcomes of medical illnesses, promotes disability, increases expense, and complicates care by clouding the clinical picture and undermining treatment adherence, yet responds only modestly to pharmacotherapy [].Problem-solving therapy (PST) is a psychotherapy that has been used widely in psychiatry.